SD

Shenekar Dipali Pravin

Active Director Director DIN 07943119
DIN 07943119 First appointment Sep 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Shenekar Dipali Pravin

Data last updated:

Shenekar Dipali Pravin is a Director at Saffronmusk Remedies Private Limited (since 2017). The company operates in Business Services.

DIN 07943119
Primary Designation Director
Industry Business Services
First Appointment 26 Sep 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saffronmusk Remedies Private Limited U74999PN2017PTC172732
Director26 Sep 20172017Active

Board colleagues of Shenekar Dipali Pravin

NameDINCompanyDesignation
Shenekar Pravin Shivaji07943125Saffronmusk Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Saffronmusk Remedies Private Limited
Premium access

Shareholding and investment profile for Shenekar Dipali Pravin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shenekar Dipali Pravin

Shenekar Dipali Pravin currently holds 1 directorship: Saffronmusk Remedies Private Limited (Director, since 26 Sep 2017).

Shenekar Dipali Pravin was first appointed on 26 Sep 2017 as Director at Saffronmusk Remedies Private Limited.

The current boards of Shenekar Dipali Pravin's companies include Shenekar Pravin Shivaji (Saffronmusk Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available